Evidence map›Paper›PMID 40751188›Full record

ArticleBMC public health2025

Factors influencing Lyme borreliosis risk perception in Europe: a cross-sectional multi-country survey study.

Emily Colby, L Hannah Gould, Ye Tan, Andreas Pilz, Gordon Brestrich, Jennifer C Moisi, James H Stark

Abstract read
In one paragraph

Article in BMC public health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Emily ColbyGlobal Vaccines and Anti-Infectives Medical Affairs, Pfizer, Pfizer US Commercial Division, New York, NY, United States. emily.colby@pfizer.com.
L Hannah GouldGlobal Vaccines and Anti-Infectives Medical Affairs, Pfizer, Pfizer US Commercial Division, New York, NY, United States.
Ye TanEvidence Generation Statistics, Pfizer Research and Development, Cambridge, MA, USA.
Andreas PilzGlobal Vaccines and Anti-Infectives Medical Affairs, Pfizer Corporation Austria, Vienna, Austria.
Gordon BrestrichGlobal Vaccines and Anti-Infectives Medical Affairs, Pfizer Pharma GmbH, Berlin, Germany.
Jennifer C MoisiGlobal Vaccines and Anti-Infectives Medical Affairs, Pfizer US Commercial Division, Paris, France.
James H StarkGlobal Vaccines and Anti-Infectives Medical Affairs, Pfizer Cambridge, Cambridge, MA, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundLyme borreliosis (LB) is the most common vector-borne disease in Europe. Research on factors that shape LB risk perception in Europe is limited. This study explores the potential drivers of LB risk perception in the general adult (18-65 years) population of twenty European countries, such as urbanicity, socioeconomic status, dog ownership, gender, age, and tick and LB diagnosis history.

methodsData were obtained from a 2022 survey of 28,034 adults aged 18-65 years in twenty European countries. The survey included questions on knowledge, attitudes, and practices related to ticks and LB. Respondents were categorized into three income levels (low, middle, or high) based on country-specific income tertiles. Descriptive statistics were calculated, and differences in responses to survey items by income level were assessed using chi-square tests. Risk perception was measured from a survey question asking respondents to rate their risk of contracting LB on a five-point scale from "very low risk" to "very high risk." Ordinal logistic regression modeled the relationship between predictor variables and LB risk perception.

resultsHaving a past LB diagnosis (adjusted odds ratio [AOR]: 3.96, 95% confidence interval [CI]: 3.38-4.64) was most strongly tied to increased LB risk perception. Knowing someone with a past LB diagnosis or having a past tick bite, were also significantly associated with higher risk perception (AOR: 2.11, 95% CI: 1.97-2.27, and AOR: 1.71, 95% CI: 1.60-1.84, respectively). High-income respondents were most likely to report a past tick bite (55.4%, 95% CI: 53.5-57.3%) and a past LB diagnosis (13.5%, 95% CI: 12.1-14.8%).

conclusionsExperience with ticks and LB (i.e., via bites or diagnoses) may play a key role in shaping LB risk perception among European adults. Dog ownership and demographic factors such as gender and age may also influence LB risk perception. These results could help LB educational campaigns addressing knowledge and perception gaps.

Indexed as

Health Knowledge, Attitudes, PracticeLyme DiseaseAdolescentAdultAgedAnimalsCross-Sectional StudiesDogsEuropeFemaleHumansMaleMiddle AgedRisk AssessmentRisk FactorsSurveys and QuestionnairesEuropeLyme borreliosisRisk perceptionSurvey researchTicks

Identifiers

PMID40751188
PMCPMC12315446

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.